Skip to main content

Differential pricing policies for covid-19 vaccinations

EDM (Early Day Motion) 1586: tabled on 03 March 2021

Tabled in the 2019-21 session.

This motion has been signed by 21 Members. It has not yet had any amendments submitted.

Motion text

That this House believes that the UK has both a moral and practical incentive to see the whole world vaccinated against covid-19; is concerned that differential pricing by pharmaceutical companies gravitates against that ambition by asking the poorest countries to pay more than the richest; notes that AstraZeneca is charging the European Union $2 per vaccine compared to $7 for Uganda; further notes that the Serum Institute which produces the AstraZeneca vaccine under licence, is charging $5 per vaccine in South Africa; is concerned that pharmaceutical companies which have received UK public financial support are making profits at the expense of the poorest countries; calls on the UK Government to ensure pharmaceutical companies revisit their differential pricing policies, and commit to not making a profit from the pandemic.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

In addition to the sponsors, the following Members have signed to support the motion.

There are no withdrawn signatures for this motion.